(45 days)
The Systems Integration ENDOALPHA has been designed to be used with an Olympus endoscope and ancillary equipment for central operation, central display, automatic initial setting, and interlocking operation of the ancillary equipment.
The Systems Integration ENDOALPHA has been designed to be used with an Olymous endoscope and ancillary equipment for central operation, central display, automatic initial setting, and interlocking operation of the ancillary equipment.
The ENDOALPHA integrated electrosurgical system has the following system functions.
- Centralized control from a non-sterilized area
2} Centralized control from a sterilized area - Centralized display
- Message display
- Voice reply .
- Automatic settings
- Scene settings
- Display customization
- Still image viewing
- Automatic smoke evacuation
The modifications made to the subject device are as follows:
A) Addition or deletion of recommended ancillary equipment
B) A change involving the communication interface
C) A change in the design of the Graphical User interface (GUI)
D) Addition of a voice reply function
E) Deletion of Surgeon's controller for EndoALPHA (MAJ-1140)
F) Transfer of Input/Output function for video signals to the Advanced system
G) Addition of additional connectable touch panel
H) Addition of Scene settings function
l) Addition of system components
Changes to the specifications of system components S
This document is a 510(k) summary for the Olympus Systems Integration ENDOALPHA, a system designed to integrate and control various ancillary equipment used with Olympus endoscopes. The summary focuses on establishing substantial equivalence to a predicate device, rather than providing a detailed study proving the device meets specific acceptance criteria in terms of performance metrics like accuracy, sensitivity, or specificity.
Therefore, many of the requested details about acceptance criteria, study design, and performance metrics (like sample size, ground truth, expert qualifications, MRMC study, standalone performance, and training set details) are not available in the provided text because the 510(k) premarket notification process for this type of device (an integration system, not a diagnostic or AI-driven tool) does not typically require such detailed performance studies in the same way as, for example, an AI diagnostic algorithm. The primary goal here is to demonstrate that the new device is as safe and effective as a legally marketed predicate device.
However, I can extract the available information and explain why other details are absent.
1. Table of Acceptance Criteria and Reported Device Performance
| Criteria Category | Acceptance Criteria (Not explicitly stated in this document as performance metrics) | Reported Device Performance (Summary of functional capabilities) |
|---|---|---|
| Primary Goal | Substantial Equivalence to Predicate Device (Olympus Integrated Endosurgery System EndoALPHA - K051613) | Concluded to be substantially equivalent based on intended use and operating principle. |
| Intended Use | To be used with an Olympus endoscope and ancillary equipment for central operation, central display, automatic initial setting, and interlocking operation. | Device has been designed for this intended use, which is identical to the predicate. |
| Operating Principle | Same operating principle as the predicate device. | Device uses the same operating principle as the predicate. |
| Functional Capabilities | Demonstrate integrated control and display of ancillary equipment, automatic settings, etc. | Offers centralized control (from non-sterilized and sterilized areas), centralized display, message display, voice reply, automatic settings, scene settings, display customization, still image viewing, and automatic smoke evacuation. |
| Safety and Effectiveness | General controls provisions of the Act (e.g., registration, listing, GMP, labeling, MDR). | Implied compliance with general controls to be marketed. No specific safety/effectiveness performance metrics are reported in this summary. |
| Modifications | Modifications should not raise new questions of safety or effectiveness. | Modifications A-I are listed (e.g., added/deleted ancillary equipment, GUI changes, added functions like voice reply and scene settings). The overall conclusion is substantial equivalence. |
Explanation for Missing "Acceptance Criteria" Details:
For a device like the ENDOALPHA, which is an integration and control system, "acceptance criteria" for demonstrating substantial equivalence are typically evaluated against the predicate device's functionality and safety profile, rather than quantitative performance metrics like accuracy or sensitivity. The FDA's review for a 510(k) largely focuses on whether the new device is as safe and effective as the predicate. The "performance" in this context refers to its functional capabilities and how they compare to the predicate, and whether any changes introduce new risks or questions of effectiveness.
2. Sample Size Used for the Test Set and Data Provenance
Not applicable/Not provided in the document.
This document does not describe a clinical performance study using a test set of data (e.g., images, patient records). The evaluation for this device appears to be based on engineering verification and validation, functional testing, and comparison to the predicate device's specifications and intended use.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
Not applicable/Not provided in the document.
Since there's no clinical performance study involving a "test set" with "ground truth" (e.g., diagnosing conditions), expert review for establishing ground truth is not part of this 510(k) summary for the ENDOALPHA system.
4. Adjudication Method for the Test Set
Not applicable/Not provided in the document.
No clinical test set requiring adjudication is described.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No.
This document does not mention or report the results of an MRMC study. The device is a system integration tool, not a diagnostic aid that would typically involve human readers interpreting output to improve diagnostic performance.
6. Standalone Performance Study
Not applicable/Not provided in the document in the context of diagnostic performance.
While the system itself has standalone functional performance (e.g., its ability to control equipment, display messages), the concept of "standalone performance" as it relates to AI algorithms or diagnostic tools (i.e., algorithm only without human-in-the-loop performance) is not relevant or evaluated for this type of system in this document. The document describes its functional capabilities in isolation and in integration.
7. Type of Ground Truth Used
Not applicable/Not provided in the document.
There is no mention of "ground truth" (e.g., pathology, outcomes data) as this pertains to diagnostic accuracy studies. For this system, the "truth" would refer to whether the system correctly performs its programmed functions (e.g., does it centralize control as intended, do automatic settings work). This is validated through engineering and functional testing rather than clinical "ground truth" data.
8. Sample Size for the Training Set
Not applicable/Not provided in the document.
This device is an integration and control system, not an AI/machine learning algorithm that requires a training set of data.
9. How the Ground Truth for the Training Set Was Established
Not applicable/Not provided in the document.
As there is no training set mentioned, this information is not relevant.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
JUL 2 7 2015
Olympus Medical Systems Corp. % Ms. Stacy Abbatiello Kluesner, M.S., RAC Regulatory Affairs Project Manager Olympus America, Inc. 3500 Corporate Parkway Center Valley, PA 18034-0610
Re: K100345
Trade/Device Name: SYSTEMS INTEGRATION ENDOALPHA Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: ODA, GCJ Dated (Date on orig SE Itr): February 5, 2010 Received (Date on orig SE ltr): February 24, 2010
Dear Ms. Kluesner,
This letter corrects our substantially equivalent letter of March 22, 2010.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be
{1}------------------------------------------------
Page 2 -
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safetv/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Benjamin R. Fisher -S
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known): x 100 3 4 5 Device Name: SYSTEMS INTEGRATION ENDOALPHA Indications for Use:
The Systems Integration ENDOALPHA has been designed to be used with an Olympus endoscope and ancillary equipment for central operation, central display, automatic initial setting, and interlocking operation of the ancillary equipment.
Prescription Use_ (Part 21 CFR 801 Subpart D)
--
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Habib Remine
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devic 510(k) Number
Page 1 of _ 1
{3}------------------------------------------------
K100345
Page 143
510(k) SUMMARY
MAR 2 2 2010
SYSTEMS INTEGRATION ENDOALPHA
January 29, 2010
1 General Information
1 Applicant: OLYMPUS MEDICAL SYSTEMS CORP. 2951 Ishikawa-cho, Hachioji-shi, Tokyo, Japan 192-8507 Establishment Registration No: 8010047
Official Correspondent: Stacy Abbatiello Kluesner, M.S., RAC Regulatory Affairs & Quality Assurance Olympus America Inc. 3500 Corporate Parkway PO Box 610 Center Valley, PA 18034-0610, USA Phone: 484-896-5405 FAX: 484-896-7128 Email: stacy.kluesner@olympus.com Establishment Registration No: 2429304
Manufacturer:
SHIRAKAWA OLYMPUS CO., LTD. 3-1, Aza-Ookamiyama, Ooaza-Odakura, Nishigo-mura, Nishishirakawa-gun Fukushima, JAPAN 961-8061 Establishment Registration No: 3002808148
2 Device Identification
- Device Name:
- Common Name:
- Regulation No:
- 트 Regulation Name:
- 월 Regulatory Class:
- 내 Product Code:
- Classification Panel: 월출
- Prescription Status: 물
Performance Standards:
SYSTEMS INTEGRATION ENDOALPHA
Endosurgery system 21 CFR 876.1500
Endoscope and accessories
KOG, GCJ
ll
Gastroenterology/Urology
Prescription device
None established under Section 514.
{4}------------------------------------------------
K100345
Page 2 of 3
3 Predicate Device Information
| Device Name: | Olympus Integrated Endosurgery System EndoALPHA(Control Unit for Endosurgery UCES-2) Software Version 3 |
|---|---|
| -------------- | ------------------------------------------------------------------------------------------------------------- |
- 510(k) No: K051613
Decision Date: 08/15/2005
Device Description ব
The Systems Integration ENDOALPHA has been designed to be used with an Olymous endoscope and ancillary equipment for central operation, central display, automatic initial setting, and interlocking operation of the ancillary equipment.
The ENDOALPHA integrated electrosurgical system has the following system functions.
1) Centralized control from a non-sterilized area
The ancillary equipment connected to the MEDICAL CONTROL UNIT FOR ENDOSURGERY (UCES-3) and EXTENSION UNIT FOR UCES-3 (MAJ-1827) can be controlled in a centralized way using the TOUCH PANEL FOR ENDOALPHA (MAJ-1828).
2} Centralized control from a sterilized area
- Ancillary equipment can be controlled by means of voice from a sterilized area.
Ancillary equipment can be controlled utilizing remote switches of the endoscope connected to the VIDEOSYSTEM CENTER (OLYMPUS CV-180, OLYMPUS OTV-S7Pro) in a sterilized area.
3) Centralized display
The settings of the functions of connected ancillary equipment can be displayed on the screen of the TOUCH PANEL FOR ENDOALPHA (MAJ-1828) and UNIVERSAL DISPLAY FOR ENDOALPHA (MAJ-1176).
4) Message display
Various warning and error messages can be displayed on the screen of the TOUCH PANEL FOR ENDOALPHA (MAJ-1828) and UNIVERSAL DISPLAY FOR ENDOALPHA (MAJ-1176).
-
- Voice reply .
The ancillary equipment settings, warning messages can be fed back in voice.
- Voice reply .
6) Automatic settings
The default settings of all ancillary equipment can be registered on a per-procedure basis and recalled with a one-touch operation for setting the ancillary equipment to the required settings at once.
7) Scene settings
The operations of the ancillary equipment, performed at the beginning of each scene in the procedure, can be registered and recalled with a one-touch operation for performing them at once.
8) Display customization
The contents of the display of the TOUCH PANEL FOR ENDOALPHA (MAJ-1828) and UNIVERSAL
{5}------------------------------------------------
K100345
Page 3 of 3
63456
DISPLAY FOR ENDOALPHA (MAJ-11-76) can be customized.
- Still image viewing
Still images recorded in a USB thumb drive (SDCZ8) can be viewed on the UNIVERSAL DISPLAY FOR ENDOALPHA (MAJ-1176).
10) Automatic smoke evacuation
When a recommended electrosurgical unit and/or SonoSurg Generator (SonoSurg-G2) and an insufflator are connected to the MEDICAL CONTROL UNIT FOR ENDOSURGERY (UCES-3) or EXTENSION UNIT FOR UCES-3 (MAJ-1827), the generated smoke or vapor can be evacuated automatically.
The modifications made to the subject device are as follows:
- A) Addition or deletion of recommended ancillary equipment
- B) A change involving the communication interface
- C) A change in the design of the Graphical User interface (GUI)
- D) Addition of a voice reply function
- E) Deletion of Surgeon's controller for EndoALPHA (MAJ-1140)
- F) Transfer of Input/Output function for video signals to the Advanced system
- G) Addition of additional connectable touch panel
- H) Addition of Scene settings function
- l) Addition of system components
- Changes to the specifications of system components S
ട് Intended Use
The Systems Integration ENDOALPHA has been designed to be used with an Olympus endoscope and ancillary equipment for central operation, central display, automatic initial setting, and interlocking operation of the ancillary equipment.
The intended use of the ENDOALPHA as stated above is to enable a central system to control various pieces of ancillary equipment. However, the previously cleared indications for use for each separate ancillary device dictate the type of procedures that may be performed. This information is included in the instruction manual for each ancillary piece of equipment.
The Intended Use is identical to the Intended Use previously cleared for the Olympus Integrated Endosurgery System EndoALPHA (Control Unit for Endosurgery UCES-2) Software Version 3, K051613.
6 Conclusion
The modified SYSTEMS INTEGRATION ENDOALPHA has the following similarities to the predicate device:
- Has the same intended use, l
- -Uses the same operating principle
In summary, the modified SYSTEMS INTEGRATION ENDOALPHA described in this submission is, in our opinion, substantially equivalent to the predicate device.
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.